Avanza Fonder’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.5M Buy
122,520
+11,988
+11% +$1.09M 0.2% 96
2026
Q2
$10.1M Buy
110,532
+15,261
+16% +$1.34M 0.22% 90
2026
Q1
$8.12M Buy
95,271
+319
+0.3% +$28.4K 0.22% 94
2025
Q4
$7.5M Buy
94,952
+11,054
+13% +$867K 0.19% 105
2025
Q3
$6.71M Buy
83,898
+7,316
+10% +$624K 0.17% 102
2025
Q2
$6.96M Buy
76,582
+4,660
+6% +$425K 0.21% 91
2025
Q1
$6.73M Sell
71,922
-15,465
-18% -$1.38M 0.22% 89
2024
Q4
$7.94M Buy
+87,387
New +$8.34M 0.24% 75

Other funds holding CL

Avanza Fonder's CL Position: Q3 2026 in Review

Avanza Fonder increased its Colgate-Palmolive (CL) stake by 11% in Q3 2026, buying an estimated $1.09M and bringing the position to 122,520 shares worth $10.5M. The position accounts for 0.2% of the portfolio, ranked #96.

Avanza Fonder first reported a position in CL in Q4 2024 and has held it in 8 quarters since. 1,212 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Avanza Fonder held 122,520 shares of Colgate-Palmolive worth $10.5M as of Q3 2026.
  • Avanza Fonder bought 11,988 Colgate-Palmolive shares in Q3 2026, an estimated $1.09M.
  • Colgate-Palmolive made up 0.2% of Avanza Fonder's portfolio in Q3 2026, its #96 holding.
  • Avanza Fonder first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 8 quarters since.
  • 1,212 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Avanza Fonder's 13F filing for Q3 2026, filed 13 Oct 2026.